SpyBiotech
Created in 2017
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
286 1,818Activities
Technologies
Entity types
Location
Oxford Business Park, Garsington Rd, Oxford OX4 2JZ, UK
Oxford
United Kingdom
Employees
Scale: 11-50
Estimated: 21
Engaged corporates
2
1 1Added in Motherbase
5 years, 7 months ago
biotech Value proposition
Utilizing unique protein superglue technology to develop vaccines against infectious disease and cancer worldwide
SpyBiotech is a UK-based company with a novel vaccine platform to target infectious diseases, cancer and chronic diseases.
SpyBiotech was spun out of the University of Oxford in 2017. Its proprietary protein superglue technology binds antigens to vaccine delivery platforms in a way which minimizes delivery risk and enhances immunogenicity and efficacy.
The company’s current lead candidate is against human cytomegalovirus (HCMV), with clinical studies planned for this year.
Vaccine Development
Homepage - SpyBiotech
SpyBiotech is a clinical stage biotechnology company with novel vaccine platform technologies to target infectious diseases, cancer and chronic diseases.
https://spybiotech.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Oxford Science Enterprises Startup accelerator & VC, Venture Capital and Private Equity Principals | Oxford Science Enterprises Startup accelerator & VC, Venture Capital and Private Equity Principals | Capitalistic Not partnership Not event 15 Feb 2021 30 Nov 2023 | | |
 Financial Times Media, Newspaper Publishing | Financial Times Media, Newspaper Publishing | Other 30 Sep 2021 | | |